Medikinet

Methylphenidate Hydrochloride, the active ingredient in Medikinet, is a central nervous system stimulant presented as a tablet for oral use. It treats attention deficit hyperactivity disorder and narcolepsy in children, adolescents and adults.

GNH USA supplies Medikinet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Medikinet (methylphenidate hydrochloride) is a psychostimulant used in the management of central nervous system disorders.

- Attention deficit hyperactivity disorder (children and adolescents): improves concentration, reduces hyperactivity and impulsivity. - Attention deficit hyperactivity disorder (adults): enhances focus and daily functioning. - Narcolepsy: decreases daytime sleepiness and supports sustained wakefulness.

Methylphenidate hydrochloride may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Insomnia: difficulty falling or staying asleep. - Decreased appetite: reduced food intake leading to weight loss. - Headache: mild to moderate cranial pain. - Stomach pain: abdominal discomfort or nausea. - Irritability: mood changes or increased agitation. - Increased heart rate: tachycardia without other symptoms.

Serious or Rare Side Effects: - Cardiovascular events: hypertension, arrhythmia, or myocardial infarction. - Psychosis: hallucinations or delusional thinking. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Priapism: prolonged, painful erection. - Motor or vocal tics: involuntary movements or sounds. - Growth suppression: reduced height velocity in children.

Before initiating therapy with Medikinet, several safety considerations should be addressed.

- Cardiovascular assessment: obtain baseline blood pressure and heart rate. - Growth monitoring: regularly track height and weight in pediatric patients. - Psychiatric history: watch for emergence of psychosis, mania, or severe anxiety. - Hypersensitivity screening: discontinue if signs of allergic reaction appear. - Storage: keep at ambient temperature below 25 °C, in the original container, protected from moisture and heat.

Methylphenidate can interact with a variety of medicines, altering efficacy or safety.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Certain antihypertensives (e.g., clonidine): may reduce stimulant effectiveness. - Tricyclic antidepressants: increased risk of cardiovascular side effects.

Moderate Interactions (Monitor Closely):\n- Selective serotonin reuptake inhibitors (SSRIs): potential for serotonin syndrome. - Alcohol: may exacerbate central nervous system stimulation and cardiovascular strain.